Avid Bioservices Inc (CDMO)

[freethemice]

The big news from ASCO is not about any individual drug, or company, it is the change in attitude about cancer immunotherapy.
Now that big pharma has endorsed cancer immunotherapy in a big way with their anti-CTLA-4 (Yervoy [BMS]), and anti-PD-1 (nivolumab [BMS], lambrolizumab [Merck]), and anti-PD-L1 (BMS and Roche) drugs the news is getting out. Check out this article in today's NY Times, which mentions my hero Dr. William B. Coley,
http://www.nytimes.com/2013/06/04/health/promising-new-cancer-drugs-empower-the-bodys-own-defense-system.html?ref=health&_r=0

What is encouraging doctors is that the drugs can shrink some lung cancer tumors, which have not been considered particularly susceptible to immune attack.

Peregrine is in the right place, at the right time, but so far it seems to be just the target of manipulation. Until we become partners with one of the BPs I don't expect much to happen.